oradrenaline (Drug) versus terlipressin (Drug) in patients with Liver Disease
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Acute on chronic liver failure with Hepato-renal SyndromeHealth Condition 2: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2018/02/012172
- Lead Sponsor
- Institute of liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
1.Patients with acute on chronic liver failure presenting with hepatorenal syndrome
2.Patients consented for the study protocol by signing the informed consent
Exclusion Criteria
1.Age less than 18 years
2.Decompensated cirrhotics
3.Patients undergoing renal replacement therapy (hemo-dialysis/renal transplantation).
4.Post liver transplantation patients.
5.History of coronary artery disease, ischaemic cardiomyopathy, ventricular arrhythmia, or peripheral vascular disease.
6.Patients with obstructive uropathy.
7.Patient who withdrew or non complaint to the study protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method